Literature DB >> 26505869

Patterns of Performance on the Modified Cued Recall Test in Spanish Adults With Down Syndrome With and Without Dementia.

Bessy Benejam1, Juan Fortea2, Rafael Molina-López3, Sebastià Videla4.   

Abstract

The assessment of memory decline in people with intellectual disability (ID) is more difficult than in the general population, due to a lack of appropriate instruments and to preexisting cognitive impairment. The aim of this study was to describe performance of healthy adults with Down syndrome (healthy-DS; prospectively cohort) on a Spanish version of the modified Cued Recall Test (mCRT). We also recruited retrospectively a cohort of DS subjects with Dementia of the Alzheimer's Type (DS-DAT). Healthy-DS obtained higher scores on free recall and total score than DS-DAT. Age was the main factor associated with decreasing mCRT scores. The mCRT was useful in DS subjects with ID at the upper end of the spectrum or ID in the middle range of the spectrum, and discriminated well between DS subjects with and without DAT.

Entities:  

Keywords:  Cued Recall Test; Down syndrome; dementia; intellectual disability; memory; neuropsychological assessment

Mesh:

Year:  2015        PMID: 26505869     DOI: 10.1352/1944-7558-120.6.481

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  8 in total

Review 1.  The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies.

Authors:  Bianca Alexandra Lautarescu; Anthony John Holland; Shahid H Zaman
Journal:  Neuropsychol Rev       Date:  2017-03-13       Impact factor: 7.444

2.  The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.

Authors:  Alain D Dekker; Silvia Sacco; Angelo Carfi; Bessy Benejam; Yannick Vermeiren; Gonny Beugelsdijk; Mieke Schippers; Lyanne Hassefras; José Eleveld; Sharina Grefelman; Roelie Fopma; Monique Bomer-Veenboer; Mariángeles Boti; G Danielle E Oosterling; Esther Scholten; Marleen Tollenaere; Laura Checkley; André Strydom; Gert Van Goethem; Graziano Onder; Rafael Blesa; Christine Zu Eulenburg; Antonia M W Coppus; Anne-Sophie Rebillat; Juan Fortea; Peter P De Deyn
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests.

Authors:  Bessy Benejam; Laura Videla; Eduard Vilaplana; Isabel Barroeta; Maria Carmona-Iragui; Miren Altuna; Silvia Valldeneu; Susana Fernandez; Sandra Giménez; Florencia Iulita; Diana Garzón; Alexandre Bejanin; David Bartrés-Faz; Sebastià Videla; Daniel Alcolea; Rafael Blesa; Alberto Lleó; Juan Fortea
Journal:  Alzheimers Dement (Amst)       Date:  2020-06-28

4.  Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease.

Authors:  Andrew J Aschenbrenner; R Asaad Baksh; Bessy Benejam; Jessica A Beresford-Webb; Antonia Coppus; Juan Fortea; Benjamin L Handen; Sigan Hartley; Elizabeth Head; Judith Jaeger; Johannes Levin; Sandra V Loosli; Anne-Sophie Rebillat; Silvia Sacco; Frederick A Schmitt; Kate E Thurlow; Shahid Zaman; Jason Hassenstab; Andre Strydom
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-02

5.  Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease.

Authors:  Bessy Benejam; Mateus Rozalem Aranha; Laura Videla; Concepción Padilla; Silvia Valldeneu; Susana Fernández; Miren Altuna; Maria Carmona-Iragui; Isabel Barroeta; Maria Florencia Iulita; Víctor Montal; Jordi Pegueroles; Alexandre Bejanin; Sandra Giménez; Sofía González-Ortiz; Sebastián Videla; David Bartrés-Faz; Daniel Alcolea; Rafael Blesa; Alberto Lleó; Juan Fortea
Journal:  Alzheimers Res Ther       Date:  2022-09-03       Impact factor: 8.823

6.  The Pictorial Screening Memory Test (P-MIS) for Adults with Moderate Intellectual Disability and Alzheimer's Disease.

Authors:  Emili Rodríguez-Hidalgo; Javier García-Alba; Maria Buxó; Ramon Novell; Susana Esteba-Castillo
Journal:  Int J Environ Res Public Health       Date:  2022-08-30       Impact factor: 4.614

7.  Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer's disease.

Authors:  Aitana Sogorb-Esteve; María-Salud García-Ayllón; Juan Fortea; Raquel Sánchez-Valle; Alberto Lleó; José-Luis Molinuevo; Javier Sáez-Valero
Journal:  Mol Neurodegener       Date:  2016-09-29       Impact factor: 14.195

8.  VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome.

Authors:  Alberto Lleó; Maria Carmona-Iragui; Laura Videla; Susana Fernández; Bessy Benejam; Jordi Pegueroles; Isabel Barroeta; Miren Altuna; Silvia Valldeneu; Mei-Fang Xiao; Desheng Xu; Raúl Núñez-Llaves; Marta Querol-Vilaseca; Sònia Sirisi; Alexandre Bejanin; M Florencia Iulita; Jordi Clarimón; Rafael Blesa; Paul Worley; Daniel Alcolea; Juan Fortea; Olivia Belbin
Journal:  Alzheimers Res Ther       Date:  2021-06-28       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.